Occurrence, Risk Factors, and Outcomes of Pulmonary Barotrauma in Critically Ill COVID-19 Patients: A Retrospective Cohort Study
Table 3
The outcomes of patients with critical COVID-19 categorized by the occurrence of pulmonary barotrauma.
Variable
All patients N = 481
Barotrauma N = 49
No barotrauma N = 432
value
Tracheostomy, N (%)
45 (9.4)
10 (20.4)
35 (8.1)
0.016
ICU mortality, N (%)
148 (30.8)
29 (59.2)
119 (27.5)
<0.0001
Hospital mortality, N (%)
194 (40.3)
34 (69.4)
160 (37.0)
<0.0001
Length of stay in ICU, median (Q1, Q3)
10.0 (5.0, 19.0)
17.0 (11.0, 29.0)
9.0 (5.0, 18.0)
<0.0001
Length of stay in hospital, median (Q1, Q3)
17.0 (12.0, 28.0)
23.0 (16.5, 38.0)
17.0 (11.0, 27.0)
<0.0001
Duration of IMV, median (Q1, Q3)
11.0 (5.0, 18.0)
16.0 (9.0, 30.0)
10.0 (5.0, 18.0)
<0.0001
Calculated for patients who received invasive mechanical ventilation. IMV: invasive mechanical ventilation, ICU: intensive care unit, Q1: first quartile, and Q3: third quartile.
